Analysis of gene expression profiles in human HL-60 cell exposed to cantharidin using cDNA microarray

International Journal of Cancer

Volumn 108, Issue 2, 2004, Pages 212-218

  Zhang, Jun Ping ^a   Ying, Kang ^b   Xiao, Zhen Yu ^a   Zhoui, Bin ^a   Huang, Qing Shan ^b   Wu, Hong Mei ^c   Yin, Ming ^a   Xie, Yi ^b   Mao, Yu Min ^b   Rui, Yao Cheng ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c United Gene Holdings Ltd   (China)

Author keywords

Cantharidin; Gene expression profile; Microarray

Indexed keywords

CANTHARIDIN; COMPLEMENTARY DNA; MESSENGER RNA; TRANSCRIPTION FACTOR;

ARTICLE; CELL CYCLE; CELL PROLIFERATION; CELL STRAIN HL 60; CONTROLLED STUDY; DNA MICROARRAY; ENERGY METABOLISM; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOMODULATION; LEUKEMIA CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; UNINDEXED SEQUENCE;

CANTHARIDIN; CELL DIVISION; ENZYME INHIBITORS; GENE EXPRESSION PROFILING; HL-60 CELLS; HUMANS; LEUKEMIA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA, MESSENGER;

EID: 0346121352     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.11405     Document Type: Article

References (42)

1. Wang CC, Wu CH, Hsieh KJ, Yen KY, Yang LL. Cytotoxic effects of cantharidin on the growth of normal and carcinoma cells. Toxicology 2000;147:77-87.
2. Sakoff JA, Ackland SP, Baldwin ML, Keane MA, McCluskey A. Anticancer activity and protein phosphatase 1 and 2A inhibition of a new generation of cantharidin analogues. Invest New Drugs 2002;20:1-11.
3. Wang GS. Medical uses of mylabris in ancient China and recent studies. J Ethnopharmacol 1989;26:147-62.
4. Sieder S, Richter E, Becker K, Heins R, Steinfelder HJ. Doxorubicin-resistant LoVo adenocarcinoma cells display resistance to apoptosis induction by some but not all inhibitors of ser/thr phosphatases 1 and 2A. Toxicology 1999;134:109-15.
5. Laidley CW, Cohen E, Casida JE. Protein phosphatase in neuroblastoma cells: [3H]cantharidin binding site in relation to cytotoxicity. J Pharmacol Exp Ther 1997;280:1152-8.
6. Shalon D, Smith SJ, Brown PO. A DNA microarray system for analyzing complex DNA samples using two-color fluorescent probe hybridization. Genome Res 1996;6:639-45.
7. Marton MJ, DeRisi JL, Bennett HA, Iyer VR, Meyer MR, Roberts CJ, Stoughton R, Burchard J, Slade D, Dai H, Bassett DE, Hartwell LH Jr, Brown PO, Friend SH. Drug target validation and identification of secondary drug target effects using DNA microarrays. Nat Med 1998;4:1293-301.
8. Kudoh K, Ramanna M, Ravatn R, Elkahloun AG, Bittner ML, Meltzer PS, Trent JM, Dalton WS, Chin KV. Monitoring the expression profiles of doxorubicin-induced and doxorubicin-resistant cancer cells by cDNA microarray. Cancer Res 2000;60:4161-6.
9. Maxwell SA, Davis GE. Differential gene expression in p53-mediated apoptosis-resistant vs. apoptosis-sensitive tumor cell lines. Proc Natl Acad Sci USA 2000;97:13009-14.
10. Chang BD, Swift ME, Shen M, Fang J, Broude EV, Roninson IB. Molecular determinants of terminal growth arrest induced in tumor cells by a chemotherapeutic agent. Proc Natl Acad Sci USA 2002;99:389-94.
11. Zhou Y, Gwadry FG, Reinhold WC, Miller LD, Smith LH, Scherf U, Liu ET, Kohn KW, Pommier Y, Weinstein JN. Transcriptional regulation of mitotic genes by camptothecin-induced DNA damage: microarray analysis of dose- and time-dependent effects. Cancer Res 2002;62:1688-95.
12. Li Y, Li Y, Tang R, Xu H, Qiu M, Chen Q, Chen J, Fu Z, Ying K, Xie Y, Mao Y. Discovery and analysis of hepatocellular carcinoma genes using cDNA microarrays. J Cancer Res Clin Oncol 2002;128:369-79.
13. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
14. Wang K, Gan L, Jeffery E, Gayle M, Gown AM, Skelly M, Nelson PS, Ng WV, Schummer M, Hood L, Mulligan J. Monitoring gene expression profile changes in ovarian carcinomas using cDNA microarray. Gene 1999;229:101-8.
15. Ng L, Tan CK, Downey KM, Fisher PA. Enzymologic mechanism of calf thymus DNA polymerase delta. J Biol Chem 1991;266:11699-704.
16. Zhang J, Tan CK, McMullen B, Downey KM, So AG. Cloning of the cDNAs for the small subunits of bovine and human DNA polymerase delta and chromosomal location of the human gene (POLD2). Genomics 1995;29:179-86.
17. Kanemaki M, Kurokawa Y, Matsuura T, Makino Y, Masani A, Okazaki K, Morishita T, Tamura T. TIP49b, a new RuvB-like DNA helicase, is included in a complex together with another RuvB-like DNA helicase, TIP49a. J Biol Chem 1999;274:22437-44.
18. Gautier T, Berges T, Tollervey D, Hurt E. Nucleolar KKE/D repeat proteins Nop56p and Nop58p interact with Nop1p and are required for ribosome biogenesis. Mol Cell Biol 1997;17:7088-98.
19. Henriksson M, Luscher B. Proteins of the Myc network: essential regulators of cell growth and differentiation. Adv Cancer Res 1996;68:109-82.
20. Ratajczak MZ, Kant JA, Luger SM, Hijiya N, Zhang J, Zon G, Gewirtz AM. In vivo treatment of human leukemia in a SCID mouse model with c-myb antisense oligodeoxynucleotides. Proc Natl Acad Sci USA 1992;89:11823-7.
21. Clark EA, Golub TR, Lander ES, Hynes RO. Genomic analysis of metastasis reveals an essential role for RhoC. Nature 2000;406:532-5.
22. Maekawa M, Ishizaki T, Boku S, Watanabe N, Fujita A, Iwamatsu A, Obinata T, Ohashi K, Mizuno K, Narumiya S. Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase. Science 1999;285:895-8.
23. Ma YY, Wei SJ, Lin YC, Lung JC, Chang TC, Whang-Peng J, Liu JM, Yang DM, Yang WK, Shen CY. PIK3CA as an oncogene in cervical cancer. Oncogene 2000;19:2739-44.
24. Shayesteh L, Lu Y, Kuo WL, Baldocchi R, Godfrey T, Collins C, Pinkel D, Powell B, Mills GB, Gray JW. PIK3CA is implicated as an oncogene in ovarian cancer. Nat Genet 1999;21:99-102.
25. Mantovani A, Bottazzi B, Colotta F, Sozzani S, Ruco L. The origin and function of tumor-associated macrophages. Immunol Today 1992;13:265-70.
26. Wetzel K, Menten P, Opdenakker G, Van Damme J, Grone HJ, Giese N, Vecchi A, Sozzani S, Cornelis JJ, Rommelaere J, Dinsart C. Transduction of human MCP-3 by a parvoviral vector induces leukocyte infiltration and reduces growth of human cervical carcinoma cell xenografts. J Gene Med 2001;3:326-37.
27. Oda E, Ohki R, Murasawa H, Nemoto J, Shibue T, Yamashita T, Tokino T, Taniguchi T, Tanaka N. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 2000;288:1053-8.
28. Boyd JM, Malstrom S, Subramanian T, Venkatesh LK, Schaeper U, Elangovan B, D'Sa-Eipper C, Chinnadurai G. Adenovirus E1B 19 kDa and Bcl-2 proteins interact with a common set of cellular proteins. Cell 1994;79:341-51.
29. Das R, Hammamieh R, Neill R, Melhem M, Jett M. Expression pattern of fatty acid-binding proteins in human normal and cancer prostate cells and tissues. Clin Cancer Res 2001;7:1706-15.
30. Kane CD, Coe NR, Vanlandingham B, Krieg P, Bernlohr DA. Expression, purification, and ligand-binding analysis of recombinant keratinocyte lipid-binding protein (MAL-1), an intracellular lipid-binding found overexpressed in neoplastic skin cells. Biochemistry 1996;35:2894-900.
31. Godbout R, Bisgrove DA, Shkolny D, Day RS 3rd. Correlation of B-FABP and GFAP expression in malignant glioma. Oncogene 1998;16:1955-62.
32. Veerkamp JH, van Moerkerk HT, Prinsen CF, van Kuppevelt TH. Structural and functional studies on different human FABP types. Mol Cell Biochem 1999;192:137-42.
33. Evans TR, Kaye SB. Retinoids: present role and future potential. Br J Cancer 1999;80:1-8.
34. Mei B, Kennedy MW, Beauchamp J, Komuniecki PR, Komuniecki R. Secretion of a novel, developmentally regulated fatty acid-binding protein into the perivitelline fluid of the parasitic nematode, Ascaris suum. J Biol Chem 1997;272:9933-41.
35. Schiebel K, Weiss B, Wohrle D, Rappold G. A human pseudoautosomal gene, ADP/ATP translocase, escapes X-inactivation whereas a homologue on Xq is subject to X-inactivation. Nat Genet 1993;3:82-7.
36. Connors TD, Van Raay TJ, Petry LR, Klinger KW, Landes GM, Burn TC. The cloning of a human ABC gene (ABC3) mapping to chromosome 16p13.3. Genomics 1997;39:231-4.
37. Lee K, Belinsky MG, Bell DW, Testa JR, Kruh GD. Isolation of MOAT-B, a widely expressed multidrug resistance-associated protein/canalicular multispecific organic anion transporter-related transporter. Cancer Res 1998;58:2741-7.
38. Zhang W, Zhang J, Komuc M, Kwan K, Frank R, Nimer SD. Molecular cloning and characterization of NF-IL3A, a transcriptional activator of the human interleukin-3 promoter. Mol Cell Biol 1995;15:6055-63.
39. Samal B, Sun Y, Stearns G, Xie C, Suggs S, McNiece I. Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Mol Cell Biol 1994;14:1431-7.
40. Boulay F, Tardif M, Brouchon L, Vignais P. The human N-formylpeptide receptor. Characterization of two cDNA isolates and evidence for a new subfamily of G-protein-coupled receptors. Biochemistry 1990;29:11123-33.
41. Burger C, Wick M, Muller R. Lineage-specific regulation of cell cycle gene expression in differentiating myeloid cells. J Cell Sci 1994;107:2047-54.
42. Teraoka H, Sawai M, Yamamoto K, Tsukada K. DNA ligase I mRNA and enzyme levels in human hematopoietic cells under dimethyl sulfoxide-induced growth-arrest and differentiation. Biochem Int 1992;26:963-71.